[Evaluation of the safety, clinical and cost-effectiveness of neonatal screening for type 1 citrullinaemia, trifunctional protein deficiency, holocarboxyl synthetase deficiency, argininosuccinic aciduria and 3-methylcrotonyl-CoA carboxylase deficiency]

Record ID 32018014361
Spanish
Original Title: Evaluación de la seguridad, la efectividad clínica y económica del cribado neonatal de citrulinemia tipo 1, deficiencia de la proteína trifuncional, deficiencia de holocarboxilas sintetasa, aciduria argininosuccínica y deficiencia de 3-metilcrotonil-CoA carboxilasa.
Details
Project Status: Ongoing
Anticipated Publish Date: 2026
English language abstract: There is no English language summary available
Publication Type: Not Assigned
Country: Spain
MeSH Terms
  • Citrullinemia
  • Mitochondrial Trifunctional Protein
  • Argininosuccinic Aciduria
  • Neonatal Screening
  • Infant, Newborn
  • Metabolism, Inborn Errors
  • Amino Acid Metabolism, Inborn Errors
  • Metabolic Diseases
Contact
Organisation Name: Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
Contact Address: Carrer de Roc Boronat, 81-95 (2a planta) ES-08005 Barcelona Spain
Contact Email: atiq.aquas@gencat.cat
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.